RÉSUMÉ
BACKGROUND: Headaches are frequent neurological disorders that are yet to be unveiled and treated comprehensively worldwide. Bearing in mind that the distribution of headache subtypes in neurology clinics (NC) is essential for planning appropriate diagnostic and therapeutic approaches, the primary goals of this multi-centric study are to carry out inter-regional comparisons by using current diagnostic criteria with evaluations of neurologists to delineate headache burden. METHODS: A cross-sectional study between April 1 and May 16, 2022 was conducted with the participation of 13 countries from the Middle East, Asia, and Africa. Patients were included in the study on a specific day each week during five consecutive weeks. All volunteers over the age of 18 and whose primary cause for admission was headache were examined. The patients admitted to NC or referred from emergency services/other services were evaluated by neurologists by means of the International Classification of Headache Disorders (ICHD-3) criteria. RESULTS: Among the 13,794 patients encountered in NC, headache was the primary complaint in 30.04%. The headache patients' mean age was 42.85 ± 14.89 (18-95 years), and 74.3% were female. According to the ICHD-3 criteria, 86.7% of the main group had primary headache disorders, 33.5% had secondary headaches, 4% had painful cranial neuropathies along with other facial and headaches, and 5.2% had headaches included in the appendix part showing some overlapping conditions. While the most common primary headache was migraine without aura (36.8%), the most common secondary headache was medication-overuse headache (MOH) (9.8%). Headaches attributed to COVID-19, its secondary complications, or vaccines continue to occur at rates of 1.2%-3.5% in current neurology practice. Pain severity was significantly lower in Ivory Coast and Sudan than in Türkiye, Turkish Republic of Northern Cyprus, Iran, Egypt, Senegal, Tatarstan, and Azerbaijan (p < 0.001). CONCLUSIONS: The study showed that migraine is still the most common motive for admissions to NC in different regions. Furthermore, MOH, an avoidable disorder, is the most common secondary headache type and appears to be a significant problem in all regions. Remarkably, pain perception differs between regions, and pain intensity is lower in Africa than in other regions.
Sujet(s)
COVID-19 , Céphalées secondaires , Céphalées , Migraines , Humains , Femelle , Adulte , Adulte d'âge moyen , Mâle , Études transversales , COVID-19/complications , Céphalée/diagnostic , Céphalée/épidémiologie , Céphalée/thérapie , Céphalées/diagnostic , Céphalées/épidémiologie , Céphalées/thérapie , Migraines/diagnostic , Asie , Céphalées secondaires/diagnostic , Moyen Orient/épidémiologie , Afrique/épidémiologie , HôpitauxRÉSUMÉ
AIM: The study was conducted to determine the effect of kangaroo care on maternal attachment in preterm infants in Turkish mothers. SUBJECTS AND METHODS: The study was conducted a quasi-experimental research design between October 2015 and February 2016 in the neonatal intensive care units (NICU) of two state hospitals located in the east and west of Turkey. The study population consisted of preterm infants hospitalized in the NICU at the time of the research and met the study-group selection criteria. The study population was divided into two groups as an experimental and control group. Kangaroo care (n = 30) was provided to the infants in the experimental group by their mothers. No intervention was applied to the infants in the control group (n = 30) other than the routine practice. Data were collected by the researcher using the 'Introductory Information Form' and the 'Maternal Attachment Inventory'. Data analysis was performed with SPSS (Statistical Package for Social Sciences) 18 software package. The data were analyzed using percentile distributions, mean, standard deviation, t-test, and Chi-square test. Official permissions and ethical approval were obtained to conduct the study. RESULTS: It was determined that the experimental and control group included in the study were similar in terms of the characteristics of the baby and the mother (P> 0.05). In the study, the mean maternal attachment scale score (MAS) of the group in which the kangaroo care was provided was higher than the control group with a statistically significant difference between the groups (P < 0.05). CONCLUSION: As a result of the study, it was concluded that kangaroo care positively affects maternal attachment and it is suggested that further studies should be conducted to evaluate the effect of kangaroo care on mother-infant attachment in Turkey.
Sujet(s)
Soins du nourrisson/méthodes , Prématuré , Unités de soins intensifs néonatals , Méthode mère kangourou , Attachement à l'objet , Adulte , Femelle , Humains , Nourrisson , Nouveau-né , Relations mère-enfant , Mères , Évaluation des résultats et des processus en soins de santé , TurquieRÉSUMÉ
AIM: Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients. METHODS: A total of 130 adult hemodialysis patients were classified into two groups based on calcium antagonist usage for a period of at least 3 months as calcium antagonist users and calcium antagonist non-users. The two groups were compared cross-sectionally in a retrospective manner in terms of demographics, chronic kidney disease aetiologies, Charlson's Comorbidty Index, blood pressure, type of dialysis access, interdialytic body weight gain, cardiothoracic index, complete blood count, biochemistry, regular medication use and consumption of ESA. All independent variables that were different between the groups were subjected to logistic regression analysis. Linear regression analysis with dependent variable of hemoglobin value was also performed RESULTS: ESA consumption and blood pressure were higher, diabetic nephropathy, doxazosin and ACE inhibitor use were more frequent, and hemoglobin was lower in the calcium antagonist users. After logistic regression analysis, diabetic nephropathy, doxazosin use, ACE inhibitor use and lower hemoglobin were associated with calcium antagonist use. After lineer regression analysis, Age, BMI, gender, predialysis creatinine value, dialysis duration, systolic and diastolic blood pressure, doxazosin use, diabetes mellitus and diabetic nephropathy were not related with hemoglobin value. But, higher amount of ESA consumption, ACE inhibitor use and calcium antagonist use were significantly associated with lower hemoglobin value. CONCLUSION: CA use was associated with lower hemoglobin levels in our hemodialysis patient population.
Sujet(s)
Inhibiteurs des canaux calciques/effets indésirables , Hémoglobines/analyse , Dialyse rénale/effets indésirables , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique , Études transversales , Érythropoïèse/effets des médicaments et des substances chimiques , Femelle , Humains , Mâle , Adulte d'âge moyen , Insuffisance rénale chronique/sang , Insuffisance rénale chronique/thérapie , Études rétrospectives , Jeune adulteRÉSUMÉ
Vitamin D plays an important role in the regulation of cellular growth and cell proliferation as well as exerting immunoregulatory activities. We sought to show the influence of vitamin D on renal graft survival. Among 102 patients, 40 were treated with vitamin D (group D) and the remaining 62 cases were not, forming a control group (group C). We studied human leukocyte antigen (HLA)-DR expression on tubules, interstitial cells, peritubular capillaries (PTCs), and evaluated macrophage infiltration of the interstitium and the PTCs. Compared to group C, group D patients showed fewer acute rejection episodes. Compared to group C patients group D patients showed significantly lower degrees of tubular and interstitial HLA-DR expression as well as interstitial and PTC macrophage infiltration. In addition in the PTC, HLA-DR expression was greater and therefore PTC destruction less in group D patients (P<.001). Twenty-seven (43.5%) of 62 group C patients lost their grafts at 29.2±15 months, whereas only 7/40 (17.5%) group D patients lost their grafts at 43.2±13 months. A significant difference was noted between the two groups in regard to the time of graft loss (P<.01). Testing vitamin D therapy along with several other covariates showed an independent effect on 5-year graft survival (P<.001). These data confirmed that vitamin D therapy shows an independent positive impact on long-term graft survival, which may be explained by its immunosuppressive effects of to reduce renal HLA-DR expression and renal macrophage infiltration and in turn mitigate PTC destruction. In conclusion, these results highlighted the potential use of vitamin D in renal allograft patients.
Sujet(s)
Calcitriol/pharmacologie , Régulation de l'expression des gènes , Antigènes HLA-DR/biosynthèse , Transplantation rénale/méthodes , Adolescent , Adulte , Biopsie , Vaisseaux capillaires/métabolisme , Femelle , Rejet du greffon , Survie du greffon , Humains , Tubules rénaux/métabolisme , Macrophages/cytologie , Macrophages/métabolisme , Mâle , Adulte d'âge moyen , Études rétrospectives , Facteurs temps , Résultat thérapeutiqueRÉSUMÉ
Rapamycin (RPM) has antiangiogenic and antiproliferative effects on cells. The aim of this study was to evaluate the mechanism of RPM as a novel antifibrotic agent by assessing its effect on interstitial fibrosis (IF). Among 60 renal transplant recipients, group 1 patients (n=20) were treated with RPM and group 2 (n=40), with cyclosporine. The proportions of infiltrating macrophages and lymphocytes in the interstitium were evaluated in 1-year biopsies. The microvessels were highlightened with CD34. After an initial biopsy, the development of diffuse IF over 18 months was evaluated by follow-up biopsies. The mean microvessel density (MVD) was significantly lower among group 1 (69.3±16) versus group 2 (96.5±30; P<.001). The proportions of macrophages and lymphocytes were lower in group 1 compared to group 2 biopsies (P<.001 for both). Fourteen (35%) group 2 and only 2 (10%) group 1 cases developed IF over 18 months (P<.05). The mean MVD in the initial biopsy was 75.6±18 in cases that did not versus 120±28 among those who did develop IF (P<.001). The amount of interstitial inflammation was greater among patients who did compared with cases who did not develop IF (P<.01). The overall 1-, 3-, and 5-year graft survival rates for group 1 were 95%, 95%, and 89% versus 95%, 65%, and 45% for group 2 patients, respectively (P<.001). RPM-treated patients showed a lower incidence of diffuse IF, which can be explained by antiproliferative and antiangiogenic effects of RPM. In conclusion, RPM therapy displayed an independently positive impact on long-term graft survival.
Sujet(s)
Fibrose/prévention et contrôle , Transplantation rénale/méthodes , Néovascularisation pathologique , Sirolimus/pharmacologie , Transplantation homologue/méthodes , Adulte , Antigènes CD34/biosynthèse , Biopsie , Prolifération cellulaire , Ciclosporine/pharmacologie , Femelle , Survie du greffon , Humains , Immunosuppresseurs/pharmacologie , Inflammation , Lymphocytes/métabolisme , Macrophages/cytologie , Macrophages/métabolisme , MâleRÉSUMÉ
It has been reported that myofibroblasts are the major cells in the development of interstitial fibrosis (IF) and, therefore, chronic dysfunction in renal allografts. Our aim was two fold: first, to understand the key markers controlling tubular and glomerular epithelial-to-mesenchymal transition (EMT); second, to show the role of tubular EMT on the development of interstitial fibrosis (IF) and the role of glomerular EMT on the development of proteinuria and, therefore, graft survival. For this purpose we evaluated the vinculin- and paxillin-containing adhesion complexes and α-smooth muscle actin (α-SMA) expression on tubular cells and glomerular podocytes in first year renal allograft biopsy specimens of 74 patients. We established the proteinuric state at the time of the biopsy of all patients. Follow-up biopsy specimens of all patients were evaluated for the development of diffuse IF (≥50% of the biopsy specimen). Among 74 patients, 21 showed grade 1 and 9 showed grade 2 tubular EMT. Only 25/74 cases showed glomerular EMT. The incidence of the development of diffuse IF at 18 and 24 months after the initial biopsy and the graft loss at 5 years were higher among subjects with tubules and glomerular podocytes showing EMT (P<.001 for all). The development of IF and graft loss was significantly earlier in cases with grade 2 compared with grade 1 or no tubular EMT (P<.001 for all). The proteinuric state at the time of the biopsy showed a significant positive correlation with the glomerular EMT (P<.001). In conclusion, our results showed that renal tubular cells and glomerular podocytes can undergo epithelial-to-mesenchymal differentiation. The transformed cells with reorganized cytoskeletal features have an important role in renal allograft survival by inducing the development of diffuse IF and proteinuria.
Sujet(s)
Fibrose/anatomopathologie , Transplantation rénale/méthodes , Tubules rénaux/anatomopathologie , Actines/métabolisme , Biopsie/méthodes , Épithélium/anatomopathologie , Fibroblastes/métabolisme , Études de suivi , Humains , Glomérule rénal/métabolisme , Tubules rénaux/métabolisme , Mésoderme/anatomopathologie , Muscles lisses/métabolisme , Phénotype , Podocytes/métabolisme , Protéinurie/métabolisme , Transplantation homologueRÉSUMÉ
BACKGROUND: Genetic polymorphisms of the renin-angiotensin system (RAS) have been reported to play an important role in the pathogenesis of diabetes mellitus and hypertension. In addition, a close association has been reported between RAS and the progression of both diabetes and hypertension. But the role of RAS on the development of posttransplantation diabetes mellitus (PTDM) is not known. For this purpose we investigated the association of polymorphisms in the genes for angiotensin-converting enzyme (ACE) and angiotensinogen (AGT) with the development of PTDM. METHODS: Genotyping for ACE insertion/deletion (I/D) and AGT M235T polymorphisms was performed in 50 patients who underwent renal transplantation during a 5-year period. Group 1 consisted of 23 recipients who developed PTDM and group 2 consisted of 27 recipients that did not have PTDM. RESULTS: Of 50 patients, 13 (26%) showed the ACE DD, 21 (42%) the ACE ID, and 16 the ACE II genotype. The frequencies of AGT MM, AGT MT, and AGT TT were 0, 54%, and 46%, respectively. Compared with group 2, there were high frequencies of the AGT TT genotype in group 1 recipients (P<.001). In addition the ACE DD genotype was found significantly higher in group 1 patients compared with group 2 patients (P=.001). CONCLUSION: The high frequencies of the AGT TT genotype and ACE DD genotype in recipients may contribute to the high prevalence of PTDM. Our data suggest a synergistic effect between the ACE and AGT polymorphism in the risk of PTDM, but to support this theory a larger patient group must be studied.